Mirtazapine Tablet, Film Coated
Product Images NDC 67296-2302

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 67296-2302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (7.5 mg (30 Tablet Bottle))

Mirtazapine Tablets, USP 7.5 mg film coated tablets in a 30-tablet package. The label includes dosing instructions, storage conditions, and manufacturer details. The product is manufactured for Northstar Rx LLC and by APL Healthcare Limited in India. The label shows the NDC 72603-558-01 and features a barcode on the right side.*

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical structure of Mirtazapine, depicting its multi-ring system with nitrogen atoms and a methyl group attached, consistent with the drug's molecular representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.